Evidence map›Paper›PMID 34589140›Full record

ArticleTherapeutic advances in neurological disorders2021

Glycemic variability of acute stroke patients and clinical outcomes: a continuous glucose monitoring study.

Lina Palaiodimou, Vasileios-Arsenios Lioutas, Vaia Lambadiari, Aikaterini Theodorou, Marios Themistocleous, Laura Aponte, Georgia Papagiannopoulou, Aikaterini Foska, Eleni Bakola, Rodrigo Quispe and 7 more

Abstract read
In one paragraph

Article in Therapeutic advances in neurological disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Observational
  5. Article
  6. [Effect of glycemic variability on the efficacy of artificial pancreas systems: A real-world study].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lina PalaiodimouSecond Department of Neurology, School of Medicine, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.ORCID https://orcid.org/0000-0001-7757-609X
Vasileios-Arsenios LioutasDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Vaia LambadiariSecond Department of Internal Medicine-Propaedeutic and Diabetes Center, Medical School, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Aikaterini TheodorouSecond Department of Neurology, School of Medicine, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Marios ThemistocleousDepartment of Neurosurgery, Pediatric Hospital of Athens, Agia Sophia, Athens, Greece.
Laura AponteDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Georgia PapagiannopoulouSecond Department of Neurology, School of Medicine, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Aikaterini FoskaSecond Department of Neurology, School of Medicine, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Eleni BakolaSecond Department of Neurology, School of Medicine, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Rodrigo QuispeDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Laura MendezDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Magdy SelimDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Vera NovakDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Elias TzavellasFirst Department of Psychiatry, Aiginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Panagiotis HalvatsiotisSecond Department of Internal Medicine-Propaedeutic and Diabetes Center, Medical School, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Konstantinos VoumvourakisSecond Department of Neurology, School of Medicine, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Georgios TsivgoulisSecond Department of Neurology, School of Medicine, University General Hospital 'Attikon', National and Kapodistrian University of Athens, Rimini 1, Chaidari, Athens 12462, Greece.ORCID https://orcid.org/0000-0002-0640-3797

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGlycemic variability (GV) has been associated with worse prognosis in critically ill patients. We sought to evaluate the potential association between GV indices and clinical outcomes in acute stroke patients.

methodsConsecutive diabetic and nondiabetic, acute ischemic or hemorrhagic stroke patients underwent regular, standard-of-care finger-prick measurements and continuous glucose monitoring (CGM) for up to 96 h. Thirteen GV indices were obtained from CGM data. Clinical outcomes during hospitalization and follow-up period (90 days) were recorded. Hypoglycemic episodes disclosed by CGM but missed by finger-prick measurements were also documented.

resultsA total of 62 acute stroke patients [48 ischemic and 14 hemorrhagic, median NIHSS score: 9 (IQR: 3-16) points, mean age: 65 ± 10 years, women: 47%, nondiabetic: 79%] were enrolled. GV expressed by higher mean absolute glucose (MAG) values was associated with a lower likelihood of neurological improvement during hospitalization before and after adjusting for potential confounders (OR: 0.135, 95% CI: 0.024-0.751,

conclusionsGreater GV of acute stroke patients may be related to lower odds of neurological improvement during hospitalization. No association was disclosed between GV indices and 3-month clinical outcomes.

Indexed as

acute strokeclinical outcomescontinuous glucose monitoringglycemic variabilityhypoglycemic episodesneurological improvement

Identifiers

PMID34589140
PMCPMC8474316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.